Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.380 |
None |
0.875 |
8 |
|
2002 |
2019 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.360 |
None |
0.857 |
7 |
|
2009 |
2019 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.360 |
None |
0.857 |
7 |
|
2009 |
2019 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.320 |
None |
1.000 |
3 |
|
2007 |
2011 |
Prostatic Neoplasms
|
group |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
1722
|
31
|
0.310 |
None |
1.000 |
2 |
|
2002 |
2004 |
Mammary Neoplasms, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
527
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Mammary Carcinoma, Human
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
545
|
|
0.300 |
None |
1.000 |
1 |
|
2010 |
2010 |
Pregnancy Complications
|
group |
Female Urogenital Diseases and Pregnancy Complications
|
Pathologic Function
|
13
|
|
0.200 |
None |
1.000 |
1 |
|
2010 |
2010 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
0.905 |
21 |
|
2004 |
2020 |
Leukemia, Myelocytic, Acute
|
disease |
Neoplasms
|
Neoplastic Process
|
3111
|
6892
|
0.100 |
None |
1.000 |
10 |
|
1998 |
2014 |
Intelligence
|
phenotype |
Behavior and Behavior Mechanisms
|
Mental Process
|
645
|
2093
|
0.100 |
None |
1.000 |
2 |
3
|
2018 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
2 |
1
|
2018 |
2018 |
QT interval feature (observable entity)
|
phenotype |
|
Clinical Attribute
|
75
|
226
|
0.100 |
None |
1.000 |
1 |
1
|
2014 |
2014 |
Multiple Sclerosis
|
disease |
Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
1800
|
1022
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Alkaline phosphatase measurement
|
phenotype |
|
Laboratory Procedure
|
42
|
79
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Mesenchymal Chondrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
19
|
|
0.090 |
None |
1.000 |
9 |
|
2012 |
2019 |
Childhood Mesenchymal Chondrosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
10
|
|
0.080 |
None |
1.000 |
8 |
|
2012 |
2019 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.080 |
None |
0.875 |
8 |
|
2002 |
2019 |
Angiofibroma
|
disease |
Neoplasms
|
Neoplastic Process
|
45
|
1
|
0.070 |
None |
1.000 |
7 |
|
2012 |
2018 |
Juvenile angiofibroma
|
disease |
Neoplasms; Cardiovascular Diseases
|
Neoplastic Process
|
44
|
|
0.070 |
None |
1.000 |
7 |
|
2012 |
2018 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2018 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.060 |
None |
1.000 |
6 |
|
2004 |
2018 |
leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
2111
|
144
|
0.060 |
None |
1.000 |
6 |
|
2000 |
2014 |
Childhood Leukemia
|
disease |
Neoplasms
|
Neoplastic Process
|
1740
|
140
|
0.050 |
None |
1.000 |
5 |
|
2000 |
2014 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.050 |
None |
1.000 |
5 |
|
2012 |
2019 |